Literature DB >> 2835548

Chronic disease in goats orally infected with two isolates of the caprine arthritis-encephalitis lentivirus.

W P Cheevers1, D P Knowles, T C McGuire, D R Cunningham, D S Adams, J R Gorham.   

Abstract

Newborn Saanen goats were orally infected with two distinct biologically cloned isolates of the caprine arthritis-encephalitis lentivirus (CAEV), designated CAEV(63) (Crawford TB, Adams DS, Cheevers WP, Cork LC: Science 207:997, 1980) and CAEV (Co) (Cork LC, Hadlow WJ, Crawford TB, Gorham JR, Piper RC: J Infect Dis 129:134, 1974; Narayan O, Clements JE, Strandberg JD, Cork LC, Griffin DE: J Gen Virol 50:69, 1980). All infected goats seroconverted for antibodies to CAEV, and there were no serologic reversions. Histologic lesions consisted of chronic inflammation of variable incidence and severity in joints and mammary gland. Clinical arthritis, estimated by enlargement of carpi, correlated with severe inflammation of radiocarpal synovium. Statistical evaluations of clinical and histologic parameters indicated that chronic joint disease was significantly more frequent and more severe in the group of goats infected with CAEV(63) than in the group infected with CAEV (Co). Thus, the severity of chronic arthritis is determined in part by the relative pathogenicity of individual CAEV isolates. Analysis of the temporal development of carpal arthritis during the first 3 years of infection indicated that (a) the extent of eventual chronic disease in individual joints was apparent relatively early after infection, (b) joints with severe chronic lesions were clinically enlarged at irregular intervals and (c) the pattern of recurrent arthritis was unique for each joint. Thus, chronic arthritis develops with a progressive course which may be promoted by recrudescent inflammation. Infectious virus was recovered 3 years after infection from selected tissues of 12 of 17 CAEV(63)-infected goats and 11 of 18 CAEV(Co)-infected goats. Virus recovery was independent of the virus isolate used for experimental infection and did not correlate with the severity of lesions.

Entities:  

Mesh:

Year:  1988        PMID: 2835548

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  13 in total

1.  Type 1 and type 2 cytokine gene expression by viral gp135 surface protein-activated T lymphocytes in caprine arthritis-encephalitis lentivirus infection.

Authors:  W P Cheevers; J C Beyer; D P Knowles
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Augmentation of lymphocyte and macrophage proliferation by caprine arthritis-encephalitis virus contributes to the development of progressive arthritis.

Authors:  K L Banks; M A Jutila; C A Jacobs; F H Michaels
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

3.  Evaluation of an enzyme-linked immunosorbent assay for the detection of antibodies to caprine arthritis-encephalitis virus in goat serum.

Authors:  R A Heckert; W B McNab; S M Richardson; M R Briscoe
Journal:  Can J Vet Res       Date:  1992-07       Impact factor: 1.310

4.  Structure and genetic variability of envelope glycoproteins of two antigenic variants of caprine arthritis-encephalitis lentivirus.

Authors:  D P Knowles; W P Cheevers; T C McGuire; A L Brassfield; W G Harwood; T A Stem
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Expression in Escherichia coli and sequencing of the coding region for the capsid protein of Dutch maedi-visna virus strain ZZV 1050: application of recombinant protein in enzyme-linked immunosorbent assay for the detection of caprine and ovine lentiviruses.

Authors:  R G Zanoni; I M Nauta; U Pauli; E Peterhans
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

6.  Peripheral ovine progressive pneumonia provirus levels correlate with and predict histological tissue lesion severity in naturally infected sheep.

Authors:  Lynn M Herrmann-Hoesing; Susan M Noh; Stephen N White; Kevin R Snekvik; Thomas Truscott; Donald P Knowles
Journal:  Clin Vaccine Immunol       Date:  2009-03-04

7.  Evaluation of agar gel immunodiffusion serology using caprine and ovine lentiviral antigens for detection of antibody to caprine arthritis-encephalitis virus.

Authors:  D P Knowles; J F Evermann; C Shropshire; J VanderSchalie; D Bradway; H M Gezon; W P Cheevers
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

8.  Priming with tat-deleted caprine arthritis encephalitis virus (CAEV) proviral DNA or live virus protects goats from challenge with pathogenic CAEV.

Authors:  A Harmache; C Vitu; F Guiguen; P Russo; G Bertoni; M Pepin; R Vigne; M Suzan
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Severity of arthritis is predicted by antibody response to gp135 in chronic infection with caprine arthritis-encephalitis virus.

Authors:  D Knowles; W Cheevers; T McGuire; T Stem; J Gorham
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

10.  Glycosylation of immunodominant linear epitopes in the carboxy-terminal region of the caprine arthritis-encephalitis virus surface envelope enhances vaccine-induced type-specific and cross-reactive neutralizing antibody responses.

Authors:  J D Trujillo; N M Kumpula-McWhirter; K J Hötzel; M Gonzalez; W P Cheevers
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.